Role of mast cells in fibrosis of classical Hodgkin lymphoma
暂无分享,去创建一个
[1] S. O’Reilly. Role of interleukin‐13 in fibrosis, particularly systemic sclerosis , 2013, BioFactors.
[2] K. O'Reilly,et al. Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment. , 2001, Clinical immunology.
[3] B. Gruber. Mast cells in the pathogenesis of fibrosis , 2003, Current rheumatology reports.
[4] K. Ohshima,et al. Interleukin‐13 and interleukin‐13 receptor in Hodgkin's disease: possible autocrine mechanism and involvement in fibrosis , 2001, Histopathology.
[5] G. Dranoff,et al. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites , 1998, Nature.
[6] P. Kamper,et al. Tumour‐associated mast cells in classical Hodgkin's lymphoma: correlation with histological subtype, other tumour‐infiltrating inflammatory cell subsets and outcome , 2016, European journal of haematology.
[7] P. Hart. Regulation of the inflammatory response in asthma by mast cell products , 2001, Immunology and cell biology.
[8] L. Gu,et al. Transforming growth factor beta 1 messenger RNA in Reed-Sternberg cells in nodular sclerosing Hodgkin's disease. , 1995, Journal of clinical pathology.
[9] G. Ling,et al. Mast Cell Infiltration Is Involved in Renal Interstitial Fibrosis in a Rat Model of Protein-Overload Nephropathy , 2010, Kidney and Blood Pressure Research.
[10] T. Williams,et al. Mechanisms underlying the localisation of mast cells in tissues. , 2011, Trends in immunology.
[11] T. Wynn. Fibrotic disease and the T(H)1/T(H)2 paradigm. , 2004, Nature reviews. Immunology.
[12] C. Brightling,et al. Mast cells express IL‐13Rα1: IL‐13 promotes human lung mast cell proliferation and FcɛRI expression , 2006, Allergy.
[13] A. Longatto-Filho,et al. KIT activation in uterine cervix adenosquamous carcinomas by KIT/SCF autocrine/paracrine stimulation loops. , 2008, Gynecologic oncology.
[14] J. Smith,et al. Stem cell factor: laboratory and clinical aspects. , 2001, Blood reviews.
[15] K. Takata,et al. T helper 2 and regulatory T-cell cytokine production by mast cells: a key factor in the pathogenesis of IgG4-related disease , 2014, Modern Pathology.
[16] P. Venge,et al. Predictors of histology, tissue eosinophilia and mast cell infiltration in Hodgkin’s Lymphoma – a population‐based study , 2011, European journal of haematology.
[17] T. Wynn. Fibrotic disease and the TH1/TH2 paradigm , 2004, Nature Reviews Immunology.
[18] J. Karbach,et al. Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans , 2013, Proceedings of the National Academy of Sciences.
[19] Fu-you Liu,et al. Mast cell, a promising therapeutic target in tubulointerstitial fibrosis. , 2007, Medical hypotheses.
[20] R. Küppers,et al. Hodgkin lymphoma. , 2012, The Journal of clinical investigation.
[21] C. Pucillo,et al. Mast Cell: An Emerging Partner in Immune Interaction , 2012, Front. Immun..
[22] F. Herrmann,et al. Hodgkin's disease: a tumor with disturbed immunological pathways. , 1997, Immunology today.
[23] H. Zhou,et al. Transforming growth factor beta 1 plays an important role in inducing CD4+CD25+forhead box P3+ regulatory T cells by mast cells , 2010, Clinical and experimental immunology.
[24] G. Nilsson,et al. Stem cell factor is a chemotactic factor for human mast cells. , 1994, Journal of immunology.
[25] G. Nilsson,et al. Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma , 2002, British journal of haematology.
[26] A. Stenzl,et al. Evaluation of the KIT/stem cell factor axis in renal tumours. , 2012, Anticancer research.
[27] M. Wills-Karp,et al. Interleukin‐13 in asthma pathogenesis , 2004, Immunological reviews.
[28] H. Xiong,et al. SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. , 2008, Blood.
[29] Hiroki Takahashi,et al. The stem cell factor/c-kit receptor pathway enhances proliferation and invasion of pancreatic cancer cells , 2006, Molecular Cancer.
[30] Z. Nemes,et al. Retrospective analysis of the prognostic role of tissue eosinophil and mast cells in Hodgkin’s lymphoma , 2008, Pathology & Oncology Research.
[31] T. Mak,et al. The role of cytokines in classical Hodgkin lymphoma. , 2002, Blood.
[32] A. Caraffa,et al. Interrelationship between IL-3 and mast cells. , 2014, Journal of biological regulators and homeostatic agents.
[33] A. Demircan,et al. The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus. , 2001, Journal of clinical pathology.
[34] 水野 紘樹. Mast cells promote the growth of Hodgkin's lymphoma cell tumor by modifying the tumor microenvironment that can be perturbed by bortezomib , 2013 .
[35] Johan Lennartsson,et al. Stem cell factor receptor/c-Kit: from basic science to clinical implications. , 2012, Physiological reviews.
[36] G. Krystal,et al. Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor. , 1996, Cancer research.
[37] B. Agnarsson,et al. Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease. , 1990, The American journal of pathology.